All posts

VEXT has target slashed at Beacon

After quarterly results fell short of his expectations, Beacon Securities analyst Russell Stanley has cut his price target on Vext Science (Vext Stock Quote, Chart, News, Analysts, Financials CSE:VEXT) in half.

On November 28, Vext reported its Q3, 2023 results. The company posted Adjusted EBITDA of $1.08-million on revenue of $8.10-million, a topline that was down from $9.19-million in the same period a year prior.

“Q3 was another challenging period for all U.S. retailers, and cannabis was no exception,” CEO Eric Offenberger said.  “In an already seasonally slow period for Arizona, the consumer remained stretched, which led to continued pressure on retail price points and smaller baskets year-over-year. Despite these ongoing challenges, our team translated effective promotions into solid growth in traffic and transactions. This enabled our stores to perform better than the market and we estimate the additional share will position us well as consumer discretionary spending improves. Furthermore, we expect first harvest out of our Eloy facility in Q1 2024 and, with the sale of our Prescott Valley facility subsequent to the end of the quarter, we are focused on maximizing the sell-through of our own product through our owned retail stores, and with the goal to improve adjusted EBITDA {earnings before interest, taxes, depreciation and amortization] margins over the next several quarters.”

In a research update to clients December 4th, Stanley maintained his “Buy” rating but cut his price target on Vext from $0.80 to $0.40, implying a return of 45 per cent at the time of publication.

“We have reduced our PT from C$0.80/sh, having taken our F2024 adjusted EBITDA forecast from $22M to $17M, while updating our share count for the recent equity financing,” the analyst explained. “We continue to view VEXT as the company most levered to Ohio, where voters recently approved an adult-use legalization measure, and VEXT is predicting initial AU sales in Q3/24.”

Stanley thinks Vext will post Adjusted EBITDA of $8-million on revenue of $36-million in fiscal 2023. He expects those numbers will improve to EBITDA of $17-million on a topline of $55-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vext
Staff

Recent Posts

Is Green Thumb Industries a buy? (May, 2024)

Its first quarter numbers are in the books and Beacon Securities analyst Russell Stanley is still bullish on Green Thumb… [Read More]

6 hours ago

Is TKO stock a buy?

Following the company's first quarter results, Roth MKM analyst Eric Handler has maintained his "Buy" rating on TKO Group (TKO… [Read More]

6 hours ago

Is WELL Health stock a buy? (May, 2024)

Following the company's first quarter results, Eight Capital analyst Christian Sgro thinks there is a lot of money to be… [Read More]

6 hours ago

“You Never Get Fired for Buying Shopify”

Its first quarter results are in the books and ATB Capital Markets analyst Martin Toner has become bullish on Shopify… [Read More]

12 hours ago

Is Thinkific Labs a buy?

Following the company's first quarter results, ATB Capital analyst Martin Toner has maintained his "Sector Perform" rating on Thinkific Labs… [Read More]

1 day ago

Chorus Aviation price target trimmed at CIBC

Following first quarter results, CIBC analyst Kevin Chiang has lowered his price target on Chorus Aviation (Chorus Aviation Stock Quote,… [Read More]

2 days ago